1. Home
  2. ADXN vs SHPH Comparison

ADXN vs SHPH Comparison

Compare ADXN & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • SHPH
  • Stock Information
  • Founded
  • ADXN 2002
  • SHPH 2012
  • Country
  • ADXN Switzerland
  • SHPH United States
  • Employees
  • ADXN N/A
  • SHPH N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADXN Health Care
  • SHPH Health Care
  • Exchange
  • ADXN Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • ADXN 8.9M
  • SHPH 7.5M
  • IPO Year
  • ADXN N/A
  • SHPH 2022
  • Fundamental
  • Price
  • ADXN $8.12
  • SHPH $0.45
  • Analyst Decision
  • ADXN
  • SHPH
  • Analyst Count
  • ADXN 0
  • SHPH 0
  • Target Price
  • ADXN N/A
  • SHPH N/A
  • AVG Volume (30 Days)
  • ADXN 1.6K
  • SHPH 702.3K
  • Earning Date
  • ADXN 08-08-2024
  • SHPH 08-12-2024
  • Dividend Yield
  • ADXN N/A
  • SHPH N/A
  • EPS Growth
  • ADXN N/A
  • SHPH N/A
  • EPS
  • ADXN N/A
  • SHPH N/A
  • Revenue
  • ADXN $1,568,105.00
  • SHPH N/A
  • Revenue This Year
  • ADXN N/A
  • SHPH N/A
  • Revenue Next Year
  • ADXN N/A
  • SHPH N/A
  • P/E Ratio
  • ADXN N/A
  • SHPH N/A
  • Revenue Growth
  • ADXN N/A
  • SHPH N/A
  • 52 Week Low
  • ADXN $5.00
  • SHPH $0.35
  • 52 Week High
  • ADXN $27.90
  • SHPH $0.98
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 44.06
  • SHPH 69.87
  • Support Level
  • ADXN $8.01
  • SHPH $0.40
  • Resistance Level
  • ADXN $8.30
  • SHPH $0.54
  • Average True Range (ATR)
  • ADXN 0.20
  • SHPH 0.05
  • MACD
  • ADXN 0.05
  • SHPH 0.01
  • Stochastic Oscillator
  • ADXN 33.73
  • SHPH 72.82

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Share on Social Networks: